Journal of Pathology and Translational Medicine

Brief Case Report

A Case of Mixed Adenoneuroendocrine Carcinoma of the Common Bile Duct: Initially Diagnosed as Cholangiocarcinoma: Soon Wook Lee, In Seok Lee, Yu Kyung Cho, Jae Myung Park, Sang Woo Kim, Myung-Gyu Choi, Kyu Yong Choi, Myung Ah Lee, Tae Ho Hong, Young Kyoung You, Eun-Sun Jung; Korean J Pathol. 2014;48(6):445-448. Published online December 31, 2014; DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.6.445

8,711 View
42 Download
11 Crossref

PDF

Citations

Citations to this article as recorded by

Neuroendocrine carcinoma of the common hepatic duct coexisting with distal cholangiocarcinoma: A case report and review of literature
Fei Chen, Wei-Wei Li, Juan-Fen Mo, Min-Jie Chen, Su-Hang Wang, Shu-Ying Yang, Zheng-Wei Song
World Journal of Gastrointestinal Surgery.2024; 16(5): 1449. CrossRef
Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs
Hyung Kyu Park, Ghee Young Kwon
Journal of Korean Medical Science.2023;[Epub] CrossRef
Mixed adenoneuroendocrine carcinoma of the distal bile duct: a case report
Takashi Maeda, Kyohei Yugawa, Nao Kinjo, Hiroto Kayashima, Daisuke Imai, Koto Kawata, Shinichiro Ikeda, Keitaro Edahiro, Kazuki Takeishi, Tomohiro Iguchi, Noboru Harada, Mizuki Ninomiya, Shohei Yamaguchi, Kozo Konishi, Shinichi Tsutsui, Hiroyuki Matsuda
Surgical Case Reports.2020;[Epub] CrossRef
The clinical profiles, management, and prognostic factors of biliary mixed neuroendocrine nonneuroendocrine neoplasms
Li-Jia Wen, Jun-Hong Chen, Hong-Ji Xu, Qiong Yu, Yu Deng, Kai Liu
Medicine.2020; 99(50): e23271. CrossRef
Rapidly progressed neuroendocrine carcinoma in the extrahepatic bile duct: a case report and review of the literature
Mariko Kamiya, Naoto Yamamoto, Yuto Kamioka, Hirohide Inoue, Hirokazu Yotsumoto, Masaaki Murakawa, Toru Aoyama, Kota Washimi, Kae Kawachi, Takashi Oshima, Makoto Ueno, Norio Yukawa, Yasushi Rino, Munetaka Masuda, Soichiro Morinaga
Surgical Case Reports.2020;[Epub] CrossRef
Mixed adenoneuroendocrine carcinoma of the hepatic bile duct: a case report and review of the literature
Sulai Liu, Zhendong Zhong, Meng Xiao, Yinghui Song, Youye Zhu, Bo Hu, Zengpeng Sun, Weimin Yi, Chuang Peng
BMC Gastroenterology.2020;[Epub] CrossRef
Mixed adenoendocrine carcinoma in the extrahepatic biliary tract: A case report and literature review
Liang Zhang, Zhengtao Yang, Qing Chen, Mengxia Li, Xiaolu Zhu, Dalong Wan, Haiyang Xie, Shusen Zheng
Oncology Letters.2019;[Epub] CrossRef
Large Cell Neuroendocrine Carcinoma Coexisting with Adenocarcinoma in the Extrahepatic Bile Duct
Masami Yuda, Teruyuki Usuba, Shin Hagiwara, Masahisa Okuma, Hisatoshi Asano, Hitoshi Sakuda, Hiroaki Katagi, Yoshiyuki Furukawa
The Japanese Journal of Gastroenterological Surgery.2018; 51(3): 187. CrossRef
Mixed Adenoneuroendocrine Carcinoma of the Distal Bile Duct
Chiaki Uchida, Yoshikazu Toyoki, Keinosuke Ishido, Daisuke Kudo, Norihisa Kimura, Shinji Tsutsumi, Takuji Kagiya, Toshiro Kimura, Kenichi Hakamada
The Japanese Journal of Gastroenterological Surgery.2017; 50(1): 43. CrossRef
Mixed adenoneuroendocrine carcinoma of the distal bile duct: A case report
Toshiaki Komo, Toshihiko Kohashi, Akira Nakashima, Ichiro Ohmori, Jun Hihara, Hidenori Mukaida, Mayumi Kaneko, Naoki Hirabayashi
International Journal of Surgery Case Reports.2017; 39: 203. CrossRef
Common Hepatic Duct Mixed Adenoneuroendocrine Carcinoma Masquerading as Cholangiocarcinoma
Sali Priyanka Akhilesh, Yadav Kamal Sunder, Tampi Chandralekha, Parikh Samir, Wagle Prasad Kashinath
Case Reports in Gastrointestinal Medicine.2016; 2016: 1. CrossRef

Original Articles

Prognostic Significance of Glycolytic Metabolic Change Related to HIF-1alpha in Oral Squamous Cell Carcinomas.: Sook Hee Hong, Sang Young Roh, Yoon Ho Ko, Hye Sung Won, Myung Ah Lee, In Sook Woo, Jae Ho Byun, Jin Hyoung Kang, Young Seon Hong, Chan Kwon Jung, Yeon Sil Kim, Young Hoon Ju, Min Sik Kim; Korean J Pathol. 2010;44(4):360-369.; DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.4.360

4,053 View
40 Download
1 Crossref

Abstract PDF

BACKGROUND
Growing tumors adapt to a hypoxic environment and increase anaerobic glycolysis. This metabolic switch is related to aggressive behavior. We investigated the relationship between glycolytic metabolism biomarkers associated with hypoxia-inducible factor (HIF)-1alpha and prognosis.
METHODS
We performed immunohistochemical staining of HIF-1alpha, pyruvate dehydrogenase kinase (PDK) 1 and lactate dehydrogenase (LDH) 5 in 74 patients with oral squamous cell carcinoma (SCC) who had received curative radical resection.
RESULTS
High reactivity of HIF-1alpha, PDK 1 and LDH 5 was observed in 29 (39.2%), 32 (43.2%) and 54 (73.0%) patients, respectively. Expression levels of the three biomarkers were significantly correlated. All three markers were highly expressed in 16 (21.6%) patients. Elevated expression of the three markers was associated with increased invasiveness (p = 0.043) and recurrence (p = 0.017) of tumors. In survival analysis, upregulation of the three markers was additionally associated with shorter disease free survival (DFS, p = 0.001) and overall survival (OS, p = 0.002). High expression of all three markers was a strong independent prognostic factor for DFS (p = 0.030) and OS (p = 0.026).
CONCLUSIONS
Oral SCC with altered glycolytic metabolism exhibits a more invasive and aggressive phenotype. Our results indicate that glycolytic metabolism biomarkers related to HIF-1alpha may be independent prognostic factors in patients with oral SCC.

Citations

Citations to this article as recorded by

Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer
Byoung Yong Shim, Ji-Han Jung, Kang-Moon Lee, Hyung-Jin Kim, Sook Hee Hong, Sung Hwan Kim, Der Sheng Sun, Hyeon-Min Cho
International Journal of Colorectal Disease.2013; 28(3): 375. CrossRef

Expressions of Cyclin E-pathway Proteins (cyclinE, cdk2, p21, p27, p57) and Their Prognostic Significance in Non-small Cell Lung Carcinomas.: Ji Han Jung, Gyeongsin Park, Myung Ah Lee, Jae Ho Byun, Chan Kwon Jung, Heejeong Lee, Kyo Young Lee, Sang In Shim, Chang Suk Kang; Korean J Pathol. 2006;40(1):24-31.

2,018 View
23 Download

Abstract PDF: BACKGROUND
The aberrant expression of cyclins, cdk and cdk inhibitor has been shown to be involved in oncogenic transformation. The aim of this study was to investigate the expression of the cyclin E-pathway proteins (cyclin E, cdk2, p21, p27, p57) in human non-small cell lung carcinomas (NSCLC) and also to evaluate the clinical significance of these expressions.
METHODS
A total of 203 consecutive patients with completely resected pathological stage I-III NSCLC were retrospectively reviewed. The expressions of cyclin E, cdk2, p21, p27 and, p57 was examined by performing immunohistochemistry with using the tissue microarray method.
RESULTS
In the total cases, the expression levels of cyclin E, cdk2, p21, p27 and p57 were 39.9% (81/203), 48.3% (98/203), 68.0% (138/203), 32.5% (66/203) and 2.7% (5/203), respectively. The overexpression of cyclin E and cdk2 was significantly and inversely correlated with the histologic differentiation in the adenocarcinoma (p<0.05), but not in the squamous cell carcinoma. Among the clinicopathologic factors, the stage and lymph node metastasis were associated with overall survival (p<0.05). Among these proteins, the negative expression of p21 was significantly correlated with a shortened survival rate (p<0.05).
CONCLUSIONS
These data suggest that the overexpression of cyclin E and cdk2 and the loss of p21 and p27 are associated with tumor progression in NSCLC. The aberrant expression of p21 is correlated with a poor prognosis. Therefore the immunohistochemical analysis of this protein as well as the clinical stage and, lymph node metastasis may be useful tools for evaluating the prognosis of NSCLC patients.

First
Prev
Page of 1
Next
Last

Search